본문 바로가기
KERD
논문KCI 등재

Safety and feasibility of laterally extended endopelvic resection for sarcoma in the female genital tract: a prospective cohort study

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류산부인과학

초록

Objective: This study aims to evaluate the safety and feasibility of laterally extended endopelvic resection (LEER) for sarcoma in the female genital tract. Methods: We prospectively recruited gynecologic cancer patients with sarcoma arising from female genital tract who underwent LEER at Seoul National University Hospital from December 2016 to March 2021. Clinicopathologic characteristics, surgical outcomes including postoperative complications and pain control, and survival outcomes of the patients were investigated. Results: A total of nine patients were registered for this study. The median age was 56 years. Carcinosarcoma (n=2, 22%), leiomyosarcoma (n=2, 22%), and undifferentiated uterine sarcoma (n=2, 22%) were common histology types. Complete resection was achieved in 88.9%. The most common location of pelvic sidewall tumors was infra-iliac acetabulum (66.7%). The pathologic outcome showed a median tumor size of 9.0 cm and internal iliac vessel resection with pelvic sidewall muscle was performed in all patients. The median estimated blood loss was 1,600 mL (range, 300-22,300), and the patients were postoperatively admitted to the intensive care unit for median 1 day (range, 0-8). Complete response was observed in 44.4% (4/9) in radiologic studies after LEER, and median progression-free survival, treatment-related survival, and overall survival were 3.3, 19.6, and 98.9 months, respectively. Conclusion: LEER was feasible and safe in treating recurrent sarcoma presenting pelvic sidewall invasion with acceptable survival outcomes and manageable postoperative complications.

Abstract

Objective: This study aims to evaluate the safety and feasibility of laterally extended endopelvic resection (LEER) for sarcoma in the female genital tract. Methods: We prospectively recruited gynecologic cancer patients with sarcoma arising from female genital tract who underwent LEER at Seoul National University Hospital from December 2016 to March 2021. Clinicopathologic characteristics, surgical outcomes including postoperative complications and pain control, and survival outcomes of the patients were investigated. Results: A total of nine patients were registered for this study. The median age was 56 years. Carcinosarcoma (n=2, 22%), leiomyosarcoma (n=2, 22%), and undifferentiated uterine sarcoma (n=2, 22%) were common histology types. Complete resection was achieved in 88.9%. The most common location of pelvic sidewall tumors was infra-iliac acetabulum (66.7%). The pathologic outcome showed a median tumor size of 9.0 cm and internal iliac vessel resection with pelvic sidewall muscle was performed in all patients. The median estimated blood loss was 1,600 mL (range, 300-22,300), and the patients were postoperatively admitted to the intensive care unit for median 1 day (range, 0-8). Complete response was observed in 44.4% (4/9) in radiologic studies after LEER, and median progression-free survival, treatment-related survival, and overall survival were 3.3, 19.6, and 98.9 months, respectively. Conclusion: LEER was feasible and safe in treating recurrent sarcoma presenting pelvic sidewall invasion with acceptable survival outcomes and manageable postoperative complications.

참고문헌 (40)

  1. Cramer DW, "Incidence and histopathology of malignancies of the female genital organs in the United States", Am J Obstet Gynecol, 118, pp.443~460 (1974)
  2. Boll D, "Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008", Int J Gynecol Cancer, 22, pp.599~606 (2012)
  3. Mbatani N, "Uterine sarcomas", Int J Gynaecol Obstet, 143(Suppl 2), pp.51~58 (2018)
  4. Bacalbasa N, "Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages : a single-center casecontrol matched study", Anticancer Res, 34, pp.7303~7308 (2014)
  5. 하형인, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry", Obstetrics & Gynecology Science, 64(5), pp.444~453 (2021), 대한산부인과학회
  6. Francis M, "Incidence and survival of gynecologic sarcomas in England", Int J Gynecol Cancer, 25, pp.850~857 (2015)
  7. Board WHO Classification of Tumours Editorial Board, "Female genital tumours" (2020), International Agency for Research on Cancer
  8. Kurman RJ, "WHO classification of tumours of female reproductive organs" (2014), International Agency for Research on Cancer
  9. Hosh M, "Uterine sarcoma : analysis of 13, 089 cases based on surveillance, epidemiology, and end results database", Int J Gynecol Cancer, 26, pp.1098~1104 (2016)
  10. Sagae S, "Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan", Oncology, 67, pp.33~39 (2004)
  11. Cho HY, "Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics", J Obstet Gynaecol Res, 42, pp.313~318 (2016)
  12. 임가원, "FIGO Staging for Uterine Sarcomas: Can the Revised 2008 Staging System Predict Survival Outcome Better?", Yonsei Medical Journal, 55(3), pp.563~569 (2014), 연세대학교의과대학[DOI]
  13. Potikul C, "Uterine sarcoma : clinical presentation, treatment and survival outcomes in thailand", Asian Pac J Cancer Prev, 17, pp.1759~1767 (2016)
  14. Rizzo A, "Impact of chemotherapy in the adjuvant setting of early stage uterine leiomyosarcoma: a systematic review and updated meta-analysis", Cancers (Basel), 12, pp.1899~ (2020)
  15. Vaz J, "Impact of adjuvant treatment and prognostic factors in stage i uterine leiomyosarcoma patients treated in commission on cancer®-accredited facilities", Gynecol Oncol, 157, pp.121~130 (2020)
  16. Cybulska P, "Secondary surgical resection for patients with recurrent uterine leiomyosarcoma", Gynecol Oncol, 154, pp.333~337 (2019)
  17. Höckel M, "Laterally extended endopelvic resection : surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies", Am J Obstet Gynecol, 180, pp.306~312 (1999)
  18. Höckel M, "Long-term experience with(laterally)extended endopelvic resection(LEER)in relapsed pelvic malignancies", Curr Oncol Rep, 17, pp.435~ (2015)
  19. Cowie P, "Atypical presentation of intravascular leiomyomatosis mimicking advanced uterine sarcoma : modified laterally extended endopelvic resection with preservation of pelvic neural structures", BMJ Case Rep, 14, pp.e244774~ (2021)
  20. Cates JMM, "The AJCC 8th edition staging system for soft tissue sarcoma of the extremities or trunk : a cohort study of the SEER database", J Natl Compr Canc Netw, 16, pp.144~152 (2018)
  21. Brierley J, "TNM classification of malignant tumours" (2017), John Wiley & Sons, Inc
  22. Höckel M, "Laterally extended endopelvic resection(LEER)--principles and practice", Gynecol Oncol, 111, pp.S13~S17 (2008)
  23. Park SJ, "Laterally extended endopelvic resection with nephrectomy for vaginal cancer", Gynecol Oncol, 152, pp.218~219 (2019)
  24. Park SJ, "Laterally extended endopelvic resection versus chemo or targeted therapy alone for pelvic sidewall recurrence of cervical cancer", Front Oncol, 11, pp.683441~ (2021)
  25. Strong VE, "Development and assessment of memorial sloan kettering cancer center’s surgical secondary events grading system", Ann Surg Oncol, 22, pp.1061~1067 (2015)
  26. Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
  27. Dowell D, "CDC guideline for prescribing opioids for chronic pain--united states, 2016", JAMA, 315, pp.1624~1645 (2016)
  28. Gronchi A, "Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients", J Clin Oncol, 27, pp.24~30 (2009)
  29. Radaelli S, "Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma(STS)of the extremities and retroperitoneum", Surg Oncol, 25, pp.125~131 (2016)
  30. Gronchi A, "Soft tissue and visceral sarcomas : ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up☆", Ann Oncol, 32, pp.1348~1365 (2021)
  31. Asencio Pascual JM, "Update in pelvic and retroperitoneal sarcoma management: the role of compartment surgery", Cir Esp (Engl Ed), 97, pp.480~488 (2019)
  32. Anderson MW, "Compartmental anatomy : relevance to staging and biopsy of musculoskeletal tumors", AJR Am J Roentgenol, 173, pp.1663~1671 (1999)
  33. Enneking WF, "The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh", Cancer, 47, pp.1005~1022 (1981)
  34. Höckel M, "Surgical resection based on ontogenetic cancer field theory for cervical cancer : mature results from a single-centre, prospective, observational, cohort study", Lancet Oncol, 20, pp.1316~1326 (2019)
  35. Leitao MM, "Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma", Gynecol Oncol, 87, pp.287~294 (2002)
  36. Ríos I, "Undifferentiated uterine sarcoma : a rare, not well known and aggressive disease : report of 13cases", Arch Gynecol Obstet, 290, pp.993~997 (2014)
  37. Matsuzaki S, "Uterine carcinosarcoma : contemporary clinical summary, molecular updates, and future research opportunity", Gynecol Oncol, 160, pp.586~601 (2021)
  38. Hiroyuki Kanao, "Should indications for laterally extended endopelvic resection (LEER) exclude patients with sciatica?", Journal of Gynecologic Oncology, 31(5), pp.1~2 (2020), 대한부인종양학회[DOI]
  39. Kanao H, "Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma : technical feasibility and short-term oncologic outcome", Gynecol Oncol, 161, pp.34~38 (2021)
  40. Vizzielli G, "Laterally extended pelvic resection for gynaecological malignancies : a multicentric experience with out-of-the-box surgery", Ann Surg Oncol, 26, pp.523~530 (2019)

관련 논문AI추천

FIGO Staging for Uterine Sarcomas: Can the Revised 2008 Staging System Predict Survival Outcome Better?김상운, 김영태, 남은지, 임가원연세대학교의과대학 · Yonsei Medical Journal2014 · 제55권 제3호Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases강재홍, 김병기, 김지혜, 김태중, 배덕수, 백이선, 이연주, 이정원, 최철훈대한산부인과학회 · Obstetrics & Gynecology Science2019 · 제62권 제2호Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma김미경, 김현진, 김혜선, 이기헌, 이유경, 이인호, 이현미대한산부인과학회 · Obstetrics & Gynecology Science2017 · 제60권 제4호Laterally extended parametrectomyAlexandra Lavinia Cozlea, Andreea Anamaria Moldovan, Balázs Lintner, Lászlo Ungár, Mihai Emil Căpîlna, Mihai Gheorghe, Mihai Stanca대한산부인과학회 · Obstetrics & Gynecology Science2021 · 제64권 제5호Overall survival after progression in patients with uterine carcinosarcoma: a single-center retrospective cohort studyEkasak Thiangphak, Ingporn Jiamset, Kanakarn Wangrangsimakul, Rakchai Buhachat대한산부인과학회 · Obstetrics & Gynecology Science2025 · 제68권 제4호Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine CarcinosarcomasAhmet Sahbaz, Aykut Ozdemir, Elcin Telli, Ibrahim E. Ertas, Kemal Gungorduk, Mehmet Gokcu, Mehmet Harma, Muzaffer Sanci, Sevil Sayhan, Sinan Ozalp, Tufan Oge대한암학회 · Cancer Research and Treatment2015 · 제47권 제2호

이 간행물의 다른 논문 (10건)